17-70175692-G-C
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000243457.4(KCNJ2):c.653G>C(p.Arg218Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R218L) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000243457.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ2 | NM_000891.3 | c.653G>C | p.Arg218Pro | missense_variant | 2/2 | ENST00000243457.4 | NP_000882.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNJ2 | ENST00000243457.4 | c.653G>C | p.Arg218Pro | missense_variant | 2/2 | 1 | NM_000891.3 | ENSP00000243457 | P1 | |
KCNJ2 | ENST00000535240.1 | c.653G>C | p.Arg218Pro | missense_variant | 2/2 | 1 | ENSP00000441848 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Andersen Tawil syndrome;C1865018:Short QT syndrome type 3 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 218 of the KCNJ2 protein (p.Arg218Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with skeletal muscle channelopathies (PMID: 29606556). ClinVar contains an entry for this variant (Variation ID: 430545). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNJ2 protein function. This variant disrupts the p.Arg218 amino acid residue in KCNJ2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12796536, 17119796, 17221872, 22589293). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2017 | The R218P variant that is likely pathogenic was identified in the KCNJ2 gene. This variant has been previously reported in at least one family in association with Andersen-Tawil syndrome (ATS) (Krych et al., 2017). The R218P variant is also not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R218P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, pathogenic/likely pathogenic missense variants at the same residue (R218Q, R218W) and nearby residues (G215D, N216Y, N216H), have been reported in HGMD, ClinVar and/or reported at GeneDx in association with ATS (Stenson et al., 2014; ClinVar SCV000541389.1; Landrum et al., 2016), supporting the functional importance of this residue and region of the protein. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at